Skip to main content

ScienceDex / Researcher record

Du, Lanying

From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.

FY2021 NIH rank #2,347
  • Sustained Excellence
  • R01 Holder
  • Long-Funded

NIH Funding · FY2021

$2.5M
Full award amounts, FY2021
5
Records listing this PI
#2,347
By linked amount among FY2021 PIs
2011
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2011$81,0001#38,200
2012$81,0001#38,124
2014$468,6672#16,251
2015$467,4002#16,498
2017$263,4001#28,514
2018$1,975,4833#2,916
2019$1,888,9623#3,452
2020$1,922,8763#984
2021$2,492,3625#2,347
2022$2,297,9783#2,844
2023$759,3311#14,503

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20111 record
  2. FY20121 record
  3. FY20142 records
  4. FY20152 records
  5. FY20171 record
  6. FY20183 records
  7. FY20193 records
  8. FY20203 records
  9. FY2021 · selected5 records
  10. FY20223 records
  11. FY20231 record

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Du, Lanying. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2021 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2011 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2021 award records by amount

NIH award records listing Du, Lanying as a PI. Multi-PI records show the full award amount for context.

  • 7R01AI157975-02R01Contact PI
    Novel nanobodies to prevent and treat SARS-CoV-2 and other pathogenic human coronaviruses
    $766.1K
    award amount
  • 7R01AI139092-05R01Contact PI
    Structure-based design of coronavirus subunit vaccines
    $729K
    award amount
  • 7R01AI137472-05R01Contact PI
    Rational design and evaluation of novel mRNA vaccines against MERS-CoV
    $555K
    award amount
  • 5R01AI137472-04R01Contact PI
    Rational design and evaluation of novel mRNA vaccines against MERS-CoV
    $339.9K
    award amount
  • 5R01AI139092-04R01Contact PI
    Structure-based design of coronavirus subunit vaccines
    $102.5K
    award amount

Award organizations

Organizations that administered FY2021 awards listing Du, Lanying as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2011
    First NIH Award
    Georgia State University
  2. 2012
    Multi-Institutional Research
    Awards at 2 institutions
  3. 2014
    $500K Cumulative Funding
  4. 2015
    $1M Cumulative Funding
  5. 2015
    R01 Grant Holder
  6. 2018
    $2M Cumulative Funding
  7. 2018
    Entered Top 50% Nationally
    Ranked #2916
  8. 2018
    Entered Top 25% Nationally
    Ranked #2916
  9. 2019
    $5M Cumulative Funding
  10. 2020
    Entered Top 10% Nationally
    Ranked #984
  11. 2020
    Entered Top 5% Nationally
    Ranked #984
  12. 2022
    $10M Cumulative Funding